Product Code:454240
Published Date: Feb 08,2023
Pages: 93
Region: Global
Category: Chemical & Material
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine. LPI (LP Information)' newest research report, the “Thebaine Industry Forecast” looks at past sales and reviews total world Thebaine sales in 2022, providing a comprehensive analysis by region and market sector of projected Thebaine sales for 2023 through 2029. With Thebaine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thebaine industry. This Insight Report provides a comprehensive analysis of the global Thebaine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thebaine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Thebaine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thebaine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thebaine. The global Thebaine market size is projected to grow from US$ 59 million in 2022 to US$ 57 million in 2029; it is expected to grow at a CAGR of 57 from 2023 to 2029. Global Thebaine key players include Sun Pharmaceutical, Alcaliber, Tasmanian Alkaloids, TPI, Cepia-Sanofi, etc. Global top five manufacturers hold a share over 95%. United States is the largest market, with a share over 40%, followed by Spain and Australia, both have a share over 55%. In terms of product, Extraction from Poppy Straw is the largest segment, with a share over 95%. And in terms of application, the largest application is Oxycodone, followed by Hydrocodone, Buprenorphine, etc. This report presents a comprehensive overview, market shares, and growth opportunities of Thebaine market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Extraction from Poppy Straw Extraction from Opium Segmentation by application Oxycodone Hydrocodone Buprenorphine Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Sun Pharmaceutical Tasmanian Alkaloids Alcaliber TPI Cepia-Sanofi Taj Pharmaceuticals Gansu Alkaloids Key Questions Addressed in this Report What is the 10-year outlook for the global Thebaine market? What factors are driving Thebaine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Thebaine market opportunities vary by end market size? How does Thebaine break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?